Percy H. Carter, CHIEF SCIENTIFIC OFFICER at Blueprint Medicines Corp (BPMC), sold 3,530 shares at $88.80 ($313K) on 2025-03-05, disclosed to the SEC on 2025-03-07.
Seasonal sale ($313k) by CHIEF SCIENTIFIC OFFICER — this insider has traded BPMC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| BPMC | SELL | 2024-06-07 | $421K | — | Filing → |
| BPMC | SELL | 2024-06-05 | $519K | — | Filing → |
| BPMC | SELL | 2024-03-11 | $415K | — | Filing → |